TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Percentage of Participants With at Least 1 VOC That Required Admission to a Healthcare Facility
Endpoint domain: Adverse events/effects
Primary endpoint: Treatment With Parenteral Pain Medication Within 90 Days of Randomization
Endpoint domain: Adverse events/effects
Primary endpoint: Safety of EgyVax Vaccine after 1 month
Endpoint domain: Adverse events/effects
Primary endpoint: Safety of EgyVax Vaccine up to 6 months
Endpoint domain: Adverse events/effects
Primary endpoint: Loss-of-Control Eating Frequency
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in Weekly Rate of Cataplexy Attacks
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Number of participants with live birth
Endpoint domain: Mortality/survival
Primary endpoint: Patient Global Impression of Improvement-Incontinence
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Time to arrhythmia diagnosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Time to medical intervention
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: corporal cavernosal firmness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in number of suspicious nodule prostate detection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: System Usage
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: User Experience - Acceptance
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: HIV-DNA levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in procedure duration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Fetal Hemoglobin (HbF) Concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Total Hemoglobin (Hb) Concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Result from the speech test in noise (S0N0)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Results from speech tests in noise with spatially separated loudspeakers
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Result from the speech test in quiet (S0)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: success or failure of therapy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in finger flexor spasticity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: Total amount of intraoperative bleeding
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Diagnostic imaging
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: intensive care unit (ICU) stay
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: skeletal muscle strength mass (SMM)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Bladder pressure (fullness)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Bioimpedance measurements
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Visual Analogue Scale (VAS) of pain
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Cerebral metabolism
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ED50 of intrathecal hyperbaric 2% prilocaine
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in child mental health measured using the Strengths and Difficulties Questionnaire (SDQ)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Changes in child self-reported symptoms of depression using the Center for Epidemiological Studies Depression Scale for Children (CES-DC)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in Fecal Microbiome at 1 month
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Fecal Microbiome at 4 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Fecal Microbiome at 8 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: anterior drawer test at 90° of hip flexion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: O2 desaturation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Oral Mucositis Toxicity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: lesion number
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: lesion site
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: SUV
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Change in Biomarker Level
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change In Patient Assessment of Constipation Symptoms (PAC-SYM)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Incidence of osteoarticular infections
Endpoint domain: Adverse events/effects
Primary endpoint: Presence of any unsolicited systemic Adverse Events (AEs) reported within 30 minutes after vaccination
Endpoint domain: Adverse events/effects
Primary endpoint: Presence of solicited injection site and systemic reactions occurring through 7 days after vaccination
Endpoint domain: Adverse events/effects
Primary endpoint: Presence of SAEs (Serious Adverse Events) and AESIs (Adverse Events of Special Interest) throughout the study
Endpoint domain: Adverse events/effects
Primary endpoint: Area Under the Plasma Concentration-time Curve up to 30 Minutes Post-dose (AUC[0-30min])
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area Under the Plasma Concentration-time Curve From Time 0 to Infinity (AUC[0-∞])
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Recruitment Duration
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Pain NRS area under the curve
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rod and Disk Test (RDT) Mean Performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Multisensory Balance Evaluation (MBE) as Measured by the Intersection Point Height
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Subjective Visual Vertical (SVV) Mean Performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rod and Frame Test (RFT) Mean Performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sub-maximal oxygen uptake test (VO2max)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Safety profile of acarbose
Endpoint domain: Adverse events/effects
Primary endpoint: Effect of acarbose on gut microbiome
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change of symptom severity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time Weighted Sum of Pain Intensity Difference Over 24 Hours Post-Dose
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of patients developing secondary epiretinal membrane formation
Endpoint domain: Adverse events/effects
Primary endpoint: patient survival at 1 month post-transplant
Endpoint domain: Mortality/survival
Primary endpoint: graft survival at 1 month post-transplant
Endpoint domain: Mortality/survival
Primary endpoint: Soluble immune checkpoints
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Costs of Totally Robotic versus Surgeon-Assisted Robotic Lung Resection
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Craving Severity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Strength of Craving
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: impact of supportive care
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Pump adoption rate
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Alerts messages
Endpoint domain: Adverse events/effects
Primary endpoint: Errors in documenting the volume of IV medications
Endpoint domain: Adverse events/effects
Primary endpoint: App usability and acceptability
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Adherence to the app and treatment
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: App satisfaction
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Change in Child Social - Emotional and Behavioral Wellbeing
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in Child Anxiety
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in parenting confidence
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Successful first-attempt placement rate of VLMA
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Successful first-attempt placement rate of endotracheal intubation via video laryngoscopy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Number of participants with change in mean blood pressure by 20% from baseline mean blood pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Number of participants with change in heart rate by 20% from baseline heart rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Number of participants change in oxygen saturation by 20% from baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: App proficiency - Connection
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: App proficiency - Face scan age
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: App proficiency - Face scan stress
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: App proficiency - Face scan heart rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: App proficiency - Onboarding
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: App proficiency - Goal selection
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: App proficiency - Goal progress
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Participation rate at baseline
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Change in abdominal pain intensity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Ocular discomfort score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Wellbeing of Early Care and Education Workers
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Reliability of the combined peritoneal equilibrium test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Responses to treatment with TKI
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Dose-limiting toxicities (DLTs) occurrence
Endpoint domain: Adverse events/effects
Primary endpoint: Recommended Phase 2 doses (RP2Ds)
Endpoint domain: Resource use
Primary endpoint: Hits on resilience knowledge questionnaire (post-intervention)
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Ventilatory functions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Cardiovascular-related treatment change
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change from baseline in the MDS-UPDRS Part II+III total score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of pregnancies reported
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Immunogenicity post MMR-booster vaccination
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Firefighter Specific Functional Balance Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Knee Extensor Isokinetic Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Hip Abductor Isokinetic Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Number of participants with hematoma
Endpoint domain: Adverse events/effects
Primary endpoint: Number of organ replacement free-days
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Blood Sugar Regulation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Rate of silent rupture
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Time to first event of adjudicated cardiovascular death
Endpoint domain: Mortality/survival
Primary endpoint: Adjudicated hospitalization for heart failure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Shortness of Breath
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to arrhythmic mitral valve prolapse detection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Number of days with high PVC-burden ≥5%
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Number of days with complex ventricular arrhythmia (nsVT, VT, or VF)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change of body fat
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Changes in arthrogenic muscle inhibition
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Arterial Blood Pressure Control
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: premenstrual syndrome severity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pacing dependency
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Need for intensive care admission
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: SARS-CoV-2 B-cell response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: SARS-CoV-2 T-cell response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Arising of POCD
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Numeric rating pain scale (NRPS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of Home Visiting Caregivers who are pregnant or within one-year post delivery
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Sevoflurane plasma concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time-average spend hypotensive
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Aortic valve function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Evidence of disease activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Multiple Sclerosis Quality of Life (MSQOL)-54
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Change in Hamilton Rating Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Diagnostic accuracy of the SNB
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Viral Load at 1 year
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of explants and revisions at 6 months after device activation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Rate of device activation successes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Muscle Oxygen Saturation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Cerebrospinal Fluid (CSF) Aβ40 Biomarker Levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change in Cerebrospinal Fluid (CSF) Aβ42 Biomarker Levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change in Vascular Dysfunction (VD) Biomarker Levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in Scores on Montgomery-Asberg Depression Ration Scale (MADRS)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Normal sinus rhythm
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Active Ageing Scale
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Time to complete resolution of intestinal metaplasia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Rate of adequate IS breaths achieved
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Bone mineral density (BMD) of the distal femur metaphysis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Effectiveness of A.I. cardiac ultrasound technology
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Validation of nutrition risk screening tool
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Abdominal drainage complications
Endpoint domain: Adverse events/effects
Primary endpoint: Rate of Nipple Necrosis
Endpoint domain: Adverse events/effects
Primary endpoint: Detection rate of daily life walking bouts
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Error level in the estimation of walking energy expenditure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Depression symptom change
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Negative and positive affect change
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Cognitive performance: affective perceptual bias
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Participant adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Number of participants with positive replication-competent lentivirus test results
Endpoint domain: Adverse events/effects
Primary endpoint: Persistent vector sequence monitoring
Endpoint domain: Adverse events/effects
Primary endpoint: Epistaxis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Efficacy of PARP inhibitors
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: FibroScan® liver stiffness measurements
Endpoint domain: Physiological/clinical
Endpoint subdomain: Liver outcomes
Primary endpoint: FibroScan® steatosis measurements
Endpoint domain: Physiological/clinical
Endpoint subdomain: Liver outcomes
Primary endpoint: Liver biopsy results
Endpoint domain: Physiological/clinical
Endpoint subdomain: Liver outcomes
Primary endpoint: self-efficacy related to exercise
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Relapsed Free Survival
Endpoint domain: Mortality/survival
Primary endpoint: Changes in NIH-PROMIS Physical Function
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in NIH-PROMIS Pain Interference
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in Self-Reported Musculoskeletal Injuries
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Qualitative assessment of patient and family experience
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Efficacy in eradicating Staphylococcus aureus
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Fundus Autofluorescence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total Console time
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Change in disease activity biomarkers
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to Sustained Recovery Through Day 29
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of Participants With Sustained Recovery Through Day 29
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline in pre-bronchodilator FEV1 at Week 4
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Levels of Elastin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Levels of Dermis Collagen
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes